Nettacin (Netilmicin)

Netilmicin, the active ingredient in Nettacin, is a aminoglycoside antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in patients requiring topical therapy.

GNH USA supplies Nettacin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Netilmicin is used to manage bacterial ocular infections by targeting susceptible Gram‑negative and Gram‑positive organisms.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge. - Keratitis: eradicates causative bacteria, promoting corneal healing. - Other ocular bacterial infections: provides broad‑spectrum coverage for infections of the conjunctiva, cornea, and eyelid.

Topical netilmicin may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Eye irritation: mild discomfort after instillation. - Burning sensation: transient stinging on application. - Redness: conjunctival hyperemia. - Tearing: increased lacrimation. - Blurred vision: temporary visual disturbance. - Stinging: brief sharp sensation.

Serious or Rare Side Effects: - Allergic contact dermatitis: rash or swelling of the eyelid. - Corneal ulceration: worsening of corneal lesions. - Systemic ototoxicity: rare hearing impairment with extensive absorption. - Nephrotoxicity: potential kidney effects if systemic exposure occurs. - Severe hypersensitivity reactions: anaphylaxis or angioedema.

When prescribing Nettacin, clinicians should consider several safety precautions to minimize risks.

- Assess renal function: evaluate patient’s kidney status before and during therapy. - Avoid in patients with known hypersensitivity to aminoglycosides: discontinue if reaction occurs. - Confirm bacterial etiology: use only for confirmed or strongly suspected bacterial infections. - Do not wear contact lenses: remove lenses during treatment to prevent drug absorption. - Monitor for prolonged use: limit duration to reduce systemic absorption. - Store at room temperature: keep in original container, protect from light and moisture.

Netilmicin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use may increase risk of nephro‑ and ototoxicity. - Neuromuscular blocking agents: may potentiate muscle weakness.

Moderate Interactions (Monitor Closely): - Topical anesthetics: may enhance corneal toxicity when used together. - Other ophthalmic antibiotics: may alter bacterial susceptibility patterns. - Non‑steroidal anti‑inflammatory eye drops: monitor for additive irritation.